{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T05:08:51Z","timestamp":1718860131182},"reference-count":39,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.taap.2013.04.022","type":"journal-article","created":{"date-parts":[[2013,5,5]],"date-time":"2013-05-05T01:00:35Z","timestamp":1367715635000},"page":"30-40","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Oral administration of drugs with hypersensitivity potential induces germinal center hyperplasia in secondary lymphoid organ\/tissue in Brown Norway rats, and this histological lesion is a promising candidate as a predictive biomarker for drug hypersensitivity occurrence in humans"],"prefix":"10.1016","volume":"271","author":[{"given":"Akitoshi","family":"Tamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izuru","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Funabashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2013.04.022_bb0005","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jaci.2004.02.046","article-title":"How do we avoid developing allergy: modifications of the TH2 response from a B-cell perspective","volume":"113","author":"Aalberse","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.taap.2013.04.022_bb0010","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/toxsci\/kfs071","article-title":"Differential gene expression responses distinguish contact and respiratory sensitizers and nonsensitizing irritants in the local lymph node assay","volume":"126","author":"Adenuga","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2013.04.022_bb0015","doi-asserted-by":"crossref","first-page":"S461","DOI":"10.1067\/mai.2002.122214","article-title":"Task force report: future research needs for the prevention and management of immune-mediated drug hypersensitivity reactions","volume":"109","author":"Adkinson","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.taap.2013.04.022_bb0020","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1002\/eji.1830271141","article-title":"Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules","volume":"27","author":"Aiba","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.taap.2013.04.022_bb0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.taap.2005.06.018","article-title":"The cytokine-dependent MUTZ-3 cell line as an in vitro model for the screening of contact sensitizers","volume":"212","author":"Azam","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2013.04.022_bb0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tox.2004.12.030","article-title":"Clinical relevance of preclinical testing for allergic side effects","volume":"209","author":"Bala","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2013.04.022_bb0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1517\/17425255.2.2.249","article-title":"Methods of evaluating immunotoxicity","volume":"2","author":"Descotes","year":"2006","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.taap.2013.04.022_bb0040","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1001\/jama.1997.03550220101014","article-title":"Allergic reactions to drugs and biologic agents","volume":"278","author":"deShazo","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.taap.2013.04.022_bb0045","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.4049\/jimmunol.1000889","article-title":"Drug antigenicity, immunogenicity, and costimulatory signaling: evidence for formation of a functional antigen through immune cell metabolism","volume":"185","author":"Elsheikh","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2013.04.022_bb0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.taap.2005.03.010","article-title":"Macrophages are involved in hexachlorobenzene-induced adverse immune effects","volume":"209","author":"Ezendam","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2013.04.022_bb0055","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0889-8561(22)00056-X","article-title":"Drug-induced autoimmune and hematologic disorders","volume":"11","author":"Gilliland","year":"1991","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"10.1016\/j.taap.2013.04.022_bb0060","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0090-1229(81)90026-X","article-title":"Studies on the mechanism of drug sensitization: T-cell-dependent popliteal lymph node reaction to diphenylhydantoin","volume":"18","author":"Gleichmann","year":"1981","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.taap.2013.04.022_bb0065","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.all.0000173785.81024.33","article-title":"Epidemiology of hypersensitivity drug reactions","volume":"5","author":"Gomes","year":"2005","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.taap.2013.04.022_bb0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0167-5699(98)80012-1","article-title":"Allergic and autoimmune reactions to xenobiotics: how do they arise?","volume":"19","author":"Griem","year":"1998","journal-title":"Immunol. Today"},{"key":"10.1016\/j.taap.2013.04.022_bb0075","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-00663-0_2","article-title":"Drug hypersensitivity reactions involving skin","volume":"29\u201355","author":"Hausmann","year":"2010","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.taap.2013.04.022_bb0080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.taap.2005.03.019","article-title":"Relationship of CD86 surface marker expression and cytotoxicity on dendritic cells exposed to chemical allergen","volume":"209","author":"Hulette","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2013.04.022_bb0085","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.14219\/jada.archive.1994.0180","article-title":"Identifying true lidocaine allergy","volume":"125","author":"Jackson","year":"1994","journal-title":"J. Am. Dent. Assoc."},{"key":"10.1016\/j.taap.2013.04.022_bb0090","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/j.jaci.2009.10.028","article-title":"Drug allergy","volume":"125","author":"Khan","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.taap.2013.04.022_bb0095","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.taap.2005.01.031","article-title":"Recent advances using rodent models for predicting human allergenicity","volume":"207","author":"Knippels","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2013.04.022_bb0100","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1084\/jem.61.5.643","article-title":"Studies on the sensitization of animals with simple chemical compounds","volume":"61","author":"Landsteiner","year":"1935","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.taap.2013.04.022_bb0105","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/eji.200324406","article-title":"Drug-induced autoantibody formation in mice: triggering by primed CD4+CD25\u2212 T cells, prevention by primed CD4+CD25+ T cells","volume":"34","author":"Layland","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.taap.2013.04.022_bb0110","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1046\/j.1365-3083.2001.00998.x","article-title":"CD80(B7.1) and CD86(B7.2) do not have distinct roles in setting the Th1\/Th2 balance in autoimmunity in rats","volume":"54","author":"MacPhee","year":"2001","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.taap.2013.04.022_bb0115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/15476910490496258","article-title":"Investigation of the involvement of macrophages and T cells in D-penicillamine-induced autoimmunity in the Brown Norway rat","volume":"1","author":"Masson","year":"2004","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.taap.2013.04.022_bb0120","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, danger, and the extended family","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.taap.2013.04.022_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.iac.2004.03.007","article-title":"Dermatologic drug reactions","volume":"24","author":"McKenna","year":"2004","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"10.1016\/j.taap.2013.04.022_bb0130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2165\/00002018-200023060-00002","article-title":"Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment","volume":"23","author":"Naisbitt","year":"2000","journal-title":"Drug Saf."},{"key":"10.1016\/j.taap.2013.04.022_bb0135","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/rtph.2000.1399","article-title":"Concordance of the toxicity of pharmaceuticals in humans and in animals","volume":"32","author":"Olson","year":"2000","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"Suppl. 5","key":"10.1016\/j.taap.2013.04.022_bb0140","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1289\/ehp.99107s5673","article-title":"Screening tests for autoimmune-related immunotoxicity","volume":"107","author":"Pieters","year":"1999","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2013.04.022_bb0145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-4274(01)00487-8","article-title":"Predictive testing for autoimmunity","volume":"127","author":"Pieters","year":"2002","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2013.04.022_bb0150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0300-483X(02)00255-X","article-title":"The danger hypothesis\u2014potential role in idiosyncratic drug reactions","volume":"181\u2013182","author":"Pirmohamed","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2013.04.022_bb0155","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1021\/tx0498197","article-title":"Investigating the role of 2-phenylpropenal in felbamate-induced idiosyncratic drug reactions","volume":"17","author":"Popovic","year":"2004","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2013.04.022_bb0160","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2165\/00139709-200423040-00006","article-title":"Drug-induced hypersensitivity: role in drug development","volume":"23","author":"Ratajczak","year":"2004","journal-title":"Toxicol. Rev."},{"key":"10.1016\/j.taap.2013.04.022_bb0165","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1517\/14740330902933736","article-title":"Immune mediation of hypersensitivity adverse drug reactions: implications for therapy","volume":"8","author":"Rieder","year":"2009","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.taap.2013.04.022_bb0170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tox.2004.12.022","article-title":"Clinical heterogeneity of drug hypersensitivity","volume":"209","author":"Roujeau","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2013.04.022_bb0175","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1398-9995.2009.02307.x","article-title":"CD8+ T cells mediate skin allergy to amoxicillin in a mouse model","volume":"65","author":"Rozieres","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.taap.2013.04.022_bb0180","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","article-title":"Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self","volume":"6","author":"Sakaguchi","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.taap.2013.04.022_bb0185","doi-asserted-by":"crossref","first-page":"E914","DOI":"10.1208\/aapsj070489","article-title":"Role of animal models in the study of drug-induced hypersensitivity reactions","volume":"7","author":"Uetrecht","year":"2005","journal-title":"AAPS J."},{"key":"10.1016\/j.taap.2013.04.022_bb0190","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/03602530600959615","article-title":"Evaluation of which reactive metabolite, if any, is responsible for a specific idiosyncratic reaction","volume":"38","author":"Uetrecht","year":"2006","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.taap.2013.04.022_bb0195","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0300-483X(03)00267-1","article-title":"Detection of systemic hypersensitivity to drugs using standard guinea pig assays","volume":"193","author":"Weaver","year":"2003","journal-title":"Toxicology"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X13001774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X13001774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T14:00:31Z","timestamp":1688220031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X13001774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0041008X13001774"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2013.04.022","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral administration of drugs with hypersensitivity potential induces germinal center hyperplasia in secondary lymphoid organ\/tissue in Brown Norway rats, and this histological lesion is a promising candidate as a predictive biomarker for drug hypersensitivity occurrence in humans","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2013.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}